Records containing: Recurrent Adult Soft Tissue Sarcoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase I Trial of Bevacizumab, Temsirolimus Alone and in Combination With Valproic Acid, or Cetuximab in Patients With Advanced Malignancy and Other Indications
-
CLINICAL_TRIALS study record update · 2026-03-10Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
-
CLINICAL_TRIALS study record update · 2025-03-20Pilot Study of High-Dose Chemotherapy With Busulfan, Melphalan, and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplant in Advanced Stage and Recurrent Tumors
-
CLINICAL_TRIALS study record update · 2025-02-10Cardiac-Sparing Whole Lung IMRT in Children and Young Adults With Lung Metastases: A Feasibility Study
-
CLINICAL_TRIALS study record update · 2025-02-07A Phase 1 and Pharmacokinetic Single Agent Study of Romidepsin in Patients With, Lymphomas, Chronic Lymphocytic Leukemia, and Select Solid Tumors and Varying Degrees of Liver Dysfunction
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-01-23Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) Trial: Adaptive Clinical Treatment (ACT)
-
CLINICAL_TRIALS study record update · 2023-10-31Phase II Randomized Study of Isolated Limb Perfusion Using Melphalan With or Without Tumor Necrosis Factor in Patients With Unresectable High Grade Soft Tissue Sarcomas of the Extremity
-
CLINICAL_TRIALS study record update · 2023-10-03A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol
-
CLINICAL_TRIALS study record update · 2023-06-15A Randomized Phase II Study of Durvalumab (MEDI4736) and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2022-08-19Phase II Study Evaluating the Role of Pazopanib in Angiosarcoma
-
CLINICAL_TRIALS study record update · 2021-02-09A Randomized, Double-Blind Phase II, Study of Gemcitabine Alone or in Combination With Pazopanib for Refractory Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2020-08-10A Phase II Study of Pazopanib With Oral Topotecan in Patients With Metastatic and Non-resectable Soft Tissue and Bone Sarcomas
-
CLINICAL_TRIALS study record update · 2020-07-29Multicenter, Open-Label Phase II Study of Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma
-
CLINICAL_TRIALS study record update · 2020-05-14A Randomized, Open-Label, Phase 2 Trial of CMB305 (Sequentially Administered LV305 and G305) and Atezolizumab in Patients With Locally Advanced, Relapsed, or Metastatic Sarcoma Expressing NY-ESO-1
-
CLINICAL_TRIALS study record update · 2019-09-12ClinicalTrials.gov study NCT02849366
-
CLINICAL_TRIALS study record update · 2018-08-21A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas
-
CLINICAL_TRIALS study record update · 2017-11-17A Phase 2 Study of Positron Emission Tomography Imaging With [18F]-Fluoromisonidazole (FMISO) and [18F]-Fluorodeoxyglucose (FDG) for Assessment of Tumor Hypoxia in Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2017-05-12A Phase II Study of Single Agent Depsipeptide (FK228) in Metastatic or Unresectable Soft Tissue Sarcomas
-
CLINICAL_TRIALS study record update · 2017-05-05A Randomized Phase II Trial of Bevacizumab (Avastin) and Temsirolimus (Torisel) in Combination With Intravenous Vinorelbine and Cyclophosphamide in Patients With Recurrent/Refractory Rhabdomyosarcoma
-
CLINICAL_TRIALS study record update · 2016-12-28Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
-
CLINICAL_TRIALS study record update · 2016-07-22A Phase 1B/II Study of GDC-0449 (NSC 747691) in Combination With RO4929097, a Gamma-Secretase Inhibitor (GSI) in Advanced/Metastatic Sarcomas
-
CLINICAL_TRIALS study record update · 2016-05-18Developmental Pathway Drug-Targets in Advanced Rhabdomyosarcomas
-
CLINICAL_TRIALS study record update · 2016-05-17A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2016-02-03A Study to Determine the Feasibility of Treating Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Using Autologous NY-ESO-1 Specific CD8+ T Cells With Cyclophosphamide Pre-conditioning But Without the Use of IL-2
-
CLINICAL_TRIALS study record update · 2015-10-05Randomized, Phase II Trial of AZD6244 Alone and AZD6244 Plus Temsirolimus for Soft-Tissue Sarcomas